Composed of a series of four guides, the OBIO Talent Toolkit stems from the success of the OBIO Health to Business Bridge (H2BB™) program which addresses an expressed need for more talent in the health science industry.
OBIO’s 2019 report describes an early adopter model to facilitate the evaluation and adoption of innovative health technologies in Ontario health organizations.
OBIO’s report, Realizing the Promise of Health Care Innovation: Increasing Value for the Patient, Health System and Economy, was published in 2013 and is a product of the Ontario Bioscience Economic Strategy Team (OBEST®), an initiative launched by OBIO to address the challenges faced by Ontario’s human health technology and bioscience industry.
OBIO’s 2018 Industry Consultation reports five recommendations from health science company executives on how to create the conditions for the growth of Ontario’s health science industry.
Bridging the Talent Gap reports on the unique value of OBIO’s Health to Business Bridge (H2BB) business internship program. This report describes how H2BB addresses the challenge of pulling top talent into Ontario’s health science industry to address the talent gap identified by 96% of Ontario’s health science company CEOs.
The “Tackling the Anchor Company Challenge Summit”, assembled industry, academic, government and investment leaders committed to working together to create a mandate of action for anchoring health science companies in Ontario.
In 2017, the Ontario Bioscience Innovation Organization convened a working group (‘OBIO Tax Policy Working Group’, OTPWG) of health science industry leaders and tax experts from academia and the private sector to examine Canada’s tax incentives and their effectiveness in stimulating growth in the health science industry.
OBIO has provided feedback to the Ministry of Research Innovation and Science on the the Province's request to recruit Ontario's First Chief Science Officer.
"The Ontario Bioscience Innovation Organization (OBIO) strongly believes that the supply chain of the future must incorporate a formal approach to creating pathways for the adoption and procurement of innovation, to benefit the people of Ontario from both a health and economic perspective."
2016 has already been a productive year for OBIO as we push forward on our advocacy efforts, expand our Health Science networks and partnerships and continue to provide access to capital for Ontario Health Science companies in order for them to reach the next level.
Gail Garland, CEO
For the full strategic review, click here
There are compelling reasons for a strong, Canadian healthcare industry. Canada has opportunities but there are barriers to success. This report presents industry’s solutions.
An organization's ability to learn, and translate that learning into action rapidly, is the ultimate competitive advantage.
As we come to the end of 2015, OBIO is proud of a year that has been characterized by recognition and support from our partners and sponsors, new learnings from the extensive feedback we received during our industry consultations and a very busy schedule as we delivered on programming and advocacy work.
Click here to read the article online
They always say time changes things, but you actually have to change them yourself.
2015 has been a year of growth and opportunity for OBIO with expanding networks and new partnerships. Since we released our five year strategic review in January 2015, there have been significant developments both within our walls and across the ecosystem.
“The best way to predict the future is to create it”
Since its founding in 2009, the Ontario Bioscience Innovation Organization (OBIO®) has been engaged in creating the future of Ontario’s biomedical sector through industry-led strategy, policy development, advocacy and high impact programming. OBIO pursues innovative thought leadership within a culture of trust, reaching out to ever growing circles of thinkers and stakeholders.